Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | 358,253 | reported | 04 May 2016 | tx 19+378,253−20,000 |
| Jazz Pharmaceuticals plc | 133,387 | reported | 05 Mar 2014 | tx 48+777,630−539,680 |
| Nuvation Bio Inc. | 123,397 | reported | 21 May 2026 | tx 12+1,778,012 |
| Axovant Sciences Ltd. | 70,000 | reported | 15 May 2017 | tx 2+123,937 |
| Arcus Biosciences, Inc. | 68,600 | reported | 10 Jun 2025 | tx 23+332,406−67,610 |
| Oruka Therapeutics, Inc. | 50,000 | reported | 25 Jun 2009 | tx 13+99,500−21,000 |
| HUMAN GENOME SCIENCES INC | 48,000 | reported | 03 Mar 2004 | tx 1+48,000 |
| Tricida, Inc. | 27,207 | reported | 15 Jun 2022 | tx 10+186,787 |
| QLT INC/BC | 22,500 | reported | 26 May 2011 | tx 3+22,500 |
| aTYR PHARMA INC | 18,000 | reported | 24 May 2016 | tx 3+43,714 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Nuvation Bio Inc. | 123,397 | 0.00 USD | deriv |
| 23 Mar 2026 | OTHER | Trade Desk, Inc. | 1,226 | 0.00 USD | |
| 23 Mar 2026 | OTHER | Trade Desk, Inc. | 212 | 59.17 USD | |
| 23 Mar 2026 | OTHER | Trade Desk, Inc. | 296 | 59.17 USD | |
| 23 Mar 2026 | OTHER | Trade Desk, Inc. | 212 | 59.17 USD | |
| 05 Mar 2026 | SALE | Trade Desk, Inc. | 50,000 | 30.48 USD | |
| 05 Mar 2026 | SALE | Trade Desk, Inc. | 102,828 | 30.45 USD | |
| 10 Jun 2025 | GRANT_AWARD | Arcus Biosciences, Inc. | 13,300 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Arcus Biosciences, Inc. | 38,300 | 0.00 USD | deriv |
| 27 May 2025 | GRANT_AWARD | Trade Desk, Inc. | 4,901 | 0.00 USD | |
| 27 May 2025 | GRANT_AWARD | Trade Desk, Inc. | 845 | 59.17 USD | |
| 27 May 2025 | GRANT_AWARD | Trade Desk, Inc. | 1,183 | 59.17 USD | |
| 27 May 2025 | GRANT_AWARD | Trade Desk, Inc. | 845 | 59.17 USD | |
| 21 May 2025 | GRANT_AWARD | Nuvation Bio Inc. | 292,983 | 0.00 USD | deriv |
| 15 Apr 2025 | GRANT_AWARD | Trade Desk, Inc. | 90 | 63.73 USD | |
| 03 Sept 2024 | GRANT_AWARD | Nuvation Bio Inc. | 200,801 | 0.00 USD | deriv |
| 13 Aug 2024 | SALE | Trade Desk, Inc. | 150,000 | 98.17 USD | |
| 06 Jun 2024 | GRANT_AWARD | Arcus Biosciences, Inc. | 8,400 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | Arcus Biosciences, Inc. | 24,000 | 0.00 USD | deriv |
| 28 May 2024 | GRANT_AWARD | Trade Desk, Inc. | 573 | 87.16 USD | |
| 28 May 2024 | GRANT_AWARD | Trade Desk, Inc. | 3,155 | 0.00 USD | |
| 28 May 2024 | GRANT_AWARD | Trade Desk, Inc. | 573 | 87.16 USD | |
| 08 Mar 2024 | CONVERSION | Trade Desk, Inc. | 103,030 | 1.80 USD | |
| 08 Mar 2024 | SALE | Trade Desk, Inc. | 102,935 | 81.90 USD | |
| 08 Mar 2024 | SALE | Trade Desk, Inc. | 95 | 82.36 USD |
6 purchases reported after at least 12 months of silence — most recent on 30 Nov 2022.